Catherine Ramsey Schulte
Stock Analyst at Robert W. Baird
(4.70)
# 777
Out of 4,707 analysts
574
Total ratings
52.9%
Success rate
11.6%
Average return
Main Sectors:
Stocks Rated by Catherine Ramsey Schulte
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Maintained: Buy | $265 → $348 | $324.14 | +7.36% | 42 | Aug 7, 2026 | |
| TWST Twist Bioscience | Maintained: Buy | $65 → $115 | $128.06 | -10.20% | 47 | Aug 4, 2026 | |
| CSTL Castle Biosciences | Maintained: Buy | $43 → $36 | $32.76 | +9.89% | 47 | Jul 31, 2026 | |
| TEM Tempus AI | Maintained: Buy | $59 | $64.29 | -8.23% | 4 | Jul 31, 2026 | |
| TECH Bio-Techne | Maintained: Hold | $49 → $73 | $72.31 | +0.95% | 43 | Jun 26, 2026 | |
| A Agilent Technologies | Maintained: Buy | $155 → $156 | $146.85 | +6.23% | 44 | May 26, 2026 | |
| MTD Mettler-Toledo International | Maintained: Hold | $1,445 → $1,194 | $1,325.52 | -9.92% | 28 | May 11, 2026 | |
| GH Guardant Health | Maintained: Buy | $120 → $129 | $160.98 | -19.87% | 2 | May 8, 2026 | |
| CAI Caris Life Sciences | Maintained: Buy | $28 → $22 | $24.82 | -11.36% | 3 | May 8, 2026 | |
| WAT Waters | Maintained: Buy | $363 → $387 | $402.91 | -3.95% | 44 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $82 → $70 | $79.10 | -11.50% | 2 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $129 → $117 | $127.08 | -7.93% | 43 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $53 → $43 | $42.38 | +1.46% | 14 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $653 → $639 | $603.02 | +5.97% | 56 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $249 → $245 | $205.23 | +19.38% | 30 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 → $3 | $7.19 | -58.28% | 23 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $11 | $15.25 | -27.87% | 28 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $109 → $137 | $211.06 | -35.09% | 54 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.22 | n/a | 8 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $102 | $96.07 | n/a | 1 | Mar 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $8 | $2.54 | n/a | 11 | Nov 2, 2018 |
Natera
Aug 7, 2026
Maintained: Buy
Price Target: $265 → $348
Current: $324.14
Upside: +7.36%
Twist Bioscience
Aug 4, 2026
Maintained: Buy
Price Target: $65 → $115
Current: $128.06
Upside: -10.20%
Castle Biosciences
Jul 31, 2026
Maintained: Buy
Price Target: $43 → $36
Current: $32.76
Upside: +9.89%
Tempus AI
Jul 31, 2026
Maintained: Buy
Price Target: $59
Current: $64.29
Upside: -8.23%
Bio-Techne
Jun 26, 2026
Maintained: Hold
Price Target: $49 → $73
Current: $72.31
Upside: +0.95%
Agilent Technologies
May 26, 2026
Maintained: Buy
Price Target: $155 → $156
Current: $146.85
Upside: +6.23%
Mettler-Toledo International
May 11, 2026
Maintained: Hold
Price Target: $1,445 → $1,194
Current: $1,325.52
Upside: -9.92%
Guardant Health
May 8, 2026
Maintained: Buy
Price Target: $120 → $129
Current: $160.98
Upside: -19.87%
Caris Life Sciences
May 8, 2026
Maintained: Buy
Price Target: $28 → $22
Current: $24.82
Upside: -11.36%
Waters
May 6, 2026
Maintained: Buy
Price Target: $363 → $387
Current: $402.91
Upside: -3.95%
May 6, 2026
Maintained: Buy
Price Target: $82 → $70
Current: $79.10
Upside: -11.50%
May 4, 2026
Maintained: Buy
Price Target: $129 → $117
Current: $127.08
Upside: -7.93%
Apr 29, 2026
Upgraded: Buy
Price Target: $53 → $43
Current: $42.38
Upside: +1.46%
Apr 24, 2026
Maintained: Buy
Price Target: $653 → $639
Current: $603.02
Upside: +5.97%
Apr 22, 2026
Maintained: Buy
Price Target: $249 → $245
Current: $205.23
Upside: +19.38%
Feb 26, 2026
Maintained: Hold
Price Target: $2 → $3
Current: $7.19
Upside: -58.28%
Feb 12, 2026
Maintained: Buy
Price Target: $17 → $11
Current: $15.25
Upside: -27.87%
Feb 6, 2026
Maintained: Hold
Price Target: $109 → $137
Current: $211.06
Upside: -35.09%
Apr 18, 2022
Rated: Hold
Price Target: n/a
Current: $0.22
Upside: n/a
Mar 4, 2019
Maintained: Buy
Price Target: $102
Current: $96.07
Upside: n/a
Nov 2, 2018
Maintained: Buy
Price Target: $9 → $8
Current: $2.54
Upside: n/a